Entity Conversion

Recorded: 2016-09-02 Pages: 9

Assignor

AROG PHARMACEUTICALS, LLC

Executed: 2014-09-30

Assignee

AROG PHARMACEUTICALS, INC.

5420 LBJ FREEWAY, SUITE 410, DALLAS, TEXAS, 75240

Covered Property (1)

Method of Inhibiting Mutant C-Kit

Patent: 9,480,683 →

Application: 14/026,886 →

Publication: US 2014/0088147

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.